IP Verse

Monosol Rx competitive analysis

Latest publications and patents of Monosol Rx New

Explore the latest publications and patents granted to Monosol Rx, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Monosol Rx

Discover the latest PTAB cases involving Monosol Rx, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Monosol Rx

IPR2017-01949Aug 15, 2017MYLANMONOSOL RXTerminated-Settled
IPR2017-01582Jun 12, 2017DR REDDYS LABORATORIESMONOSOL RXInstitution Denied
IPR2017-01557Jun 9, 2017PAR PHARMACEUTICALMONOSOL RXInstitution Denied
IPR2017-00412Dec 6, 2016MONOSOL RXICOSInstitution Denied
IPR2017-00200Nov 4, 2016MYLANMONOSOL RXTerminated-Settled
IPR2016-01112May 31, 2016DR REDDYS LABORATORIESMONOSOL RXInstitution Denied
IPR2016-01111May 31, 2016DR REDDYS LABORATORIESMONOSOL RXInstitution Denied
IPR2016-00282Dec 4, 2015TEVA PARMACEUTICALS USAMONOSOL RXInstitution Denied
IPR2016-00281Dec 4, 2015TEVA PHARMACEUTICALS USAMONOSOL RXInstitution Denied
IPR2015-00169Oct 28, 2014BIODELIVERY SCIENCESMONOSOL RXFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Monosol Rx with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MONOSOL RX - - 215Defensive
BIODELIVERY SCIENCES - - 9 - Highly Aggressive
DR REDDYS LABORATORIES9627 - Highly Aggressive
MYLAN - 25 - Highly Aggressive